KCNN4 and acute lymphoblastic leukemia: To address this hypothesis, we used a selective KCa3.1 blocker NS6180 to check whether it reduces the IL-15 and target cells (T-ALL cell line Jurkat) induced [Ca2+]i signal and SOCE in NK cells and whether KCa3.1 block affects NK degranulation and killing of Jurkat cells.